Pharmaceutical production capacity planning system (APS)

The planner combines pharmaceutical production with usable materials, equipment, staff and lab capacity. A detained batch or repair is seen in the scheduling of order deadlines.

The availability of the material or equipment envisaged in the schedule is no different from the approved permit, and the capacity of the checks and laboratory is not fully included. The work has to be rescheduled at the start of execution or additionally explained whether the intended condition is actually met.

How the solution works

  1. Orders, technical readiness and approved states of use for materials and equipment are collected.
  2. The schedule applies the process, staffing and laboratory constraints approved for the specific product.
  3. The planner compares the effects of delays and an alternative schedule on orders.
  4. The approved version is transmitted for execution, and a change in quality or equipment status initiates a review.

Key challenges

  • Planning does not reflect actual production constraints

Solution capabilities

Allowed resources used

Material and equipment are planned under the current quality and usage approval.

Process Restrictions

The conditions of campaigns, cleaning, waiting and other stages are applied according to the approved basis for a specific process.

Laboratory and human readiness

A realistically time-limiting study and suitable staff are included.

Disruption script

Detention or failure shows the affected schedule and persisting unconfirmed assumptions.

Business context

Planning does not reflect actual production constraints
The availability of the material or equipment envisaged in the schedule is no different from the approved permit, and the capacity of the checks and laboratory is not fully included. The work has to be rescheduled at the start of execution or additionally explained whether the intended condition is actually met.
Supply Promise Appreciates Quality Checks
The customer is interested in the date of production being released, so the end of production is not enough. The plan evaluates allowed materials, laboratory work and suspended batches, more accurately the order's readiness is visible. The sales team can combine delivery under real conditions and discuss possible delays early.

Core features

  • Allowed resources used
  • Process Restrictions
  • Laboratory and human readiness
  • Disruption script

Key integrations

Enterprise resource planning system (ERP) / MRP
Orders, needs, supplies and planned receipts of materials.
Production Execution System (MES)
Actual status of operations, delays and remaining work.
Warehouse management system (WMS)
Real availability of materials and reservations.
Computerised maintenance management system (CMMS)
Planned maintenance windows and facility inaccessibility.

Potential impact (%)

The ranges indicate an illustrative relative change in the metric under the stated assumptions. Results depend on the starting position and actual use of the solution. Percentages for different metrics must not be added together.

Work on rescheduling the approved timetable

6–25%Decreasing

This illustrative scenario assumes that 20-50% of waiting caused by missing information or unclear responsibility can be addressed. That share is assumed to fall by 30-50%. Company data is needed to verify both the addressable share and the resulting change.

The active timing of alignment between the planner and related commands for similar disorders is measured.

Known operating restrictions are missing from the schedule

5–25%Decreasing

This illustrative scenario assumes that 20-50% of missed actions can be identified through task and deadline tracking. That share is assumed to fall by 25-50%. Company data is needed to verify both the addressable share and the resulting change.

The works suspended due to these omissions are recorded, distinguishing the new events that subsequently occurred.

Conditional calculation scenarios. The assumptions have not been validated against client measurements.

When this solution is relevant

  • The plan is based on the predicted release of the material, which is understood by execution as an already approved permit.
  • The production sequence does not assess the required inspection, laboratory capacity or unconfirmed equipment readiness.

Project scope and implementation

The planning is connected to approved materials, equipment and laboratory data. It is possible to supplement the planning system in use with missing restrictions or to prepare a special working environment for the planner. Its validation of fitness checks and changes is compatible with the company's responsible specialists.

Further development options

  • Comparison of laboratory assumptions with actual states
  • Review of the impact of the change to the approved campaign

Frequently asked questions

Adapting the solution to your business